Loading mutual fund details…
LIC MF Healthcare Fund-Regular Plan-Growth is an equity scheme managed by LIC Mutual Fund. It has ranked in the top half of its category for 1 of the last 6 reported years. Risk-adjusted return (Sharpe ratio) is 0.00. The total expense ratio is 2.44% on assets of ₹85Cr. The fund is currently managed by Sudhanshu Asthana, appointed within the last year.
Lower is better.
This scheme classifies as Large-Blend on the 3x3 equity style box, with 72% of its portfolio classified as of 2026-04-30.
| Holding | Sector |
|---|
| Window | Min | P25 | Median |
|---|
Point-in-time CAGRs cherry-pick a single start date. The chart below shows the distribution of every possible rolling start over the fund's history, so you see the range of investor outcomes — not just one date's number.
Backtested SIP outcomes across both rolling-window scenarios and named historical stress events (COVID, Election uncertainty, Russia/Ukraine, etc.), plus per-manager alpha during their tenure on this scheme.
Same fund, monthly SIPs over rolling 1/3/5-year windows.
| Scheme | AMC | AUM | TER | 3Y |
|---|
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not indicative of future results. MintByte is an AMFI-registered Mutual Fund Distributor (ARN-314872) and APMI member (APRN-01658). MintByte does not issue buy/sell recommendations on specific securities — the site is an educational data and analytics platform. Star ratings on this page reflect a 3-year category-quartile position computed in-house and are educational only.
Mutual fund schemes are subject to market risk. Read all scheme-related documents carefully before investing. Past performance is not indicative of future results. MintByte is an AMFI-registered mutual fund distributor (ARN-314872). MintByte does not issue buy/sell recommendations on specific securities — the site is an educational data and analytics platform. Not investment advice. Methodology · How we earn.
In-house derivations using 3-year daily NAV vs benchmark. See methodology.
| Weight |
|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | Healthcare | 11.22% |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | Healthcare | 6.52% |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | Healthcare | 6.50% |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | Healthcare | 5.15% |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | Healthcare | 4.74% |
| FORTIS HEALTHCARE LIMITED. EQ | Healthcare | 4.70% |
| NEULAND LABORATORIES LIMITED EQ | Healthcare | 4.59% |
| STELIS BIOPHARMA LIMITED EQ NEW FV RE.1/- | Healthcare | 4.56% |
| PIRAMAL PHARMA LIMITED EQ | Healthcare | 4.33% |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | Healthcare | 3.41% |
| NAVIN FLUORINE INTERNATIONAL LTD EQ NEW FV RS. 2/- | Basic Materials | 3.32% |
| ALKEM LABORATORIES LIMITED EQ | Healthcare | 3.20% |
| CIPLA LIMITED EQ NEW FV RS.2/- | Healthcare | 3.03% |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | Healthcare | 3.01% |
| GLAND PHARMA LIMITED EQ NEW FV Re.1/- | Healthcare | 2.91% |
| ABBOTT INDIA LIMITED EQ | Healthcare | 2.91% |
| CONCORD BIOTECH LIMITED EQ NEW FV RE.1/- | Healthcare | 2.77% |
| ARTEMIS MEDICARE SERVICES LIMITED EQ NEW FV Re.1/- | Healthcare | 2.70% |
| METROPOLIS HEALTHCARE LIMITED EQ NEW FV RS. 2/- | Healthcare | 2.67% |
| ANTHEM BIOSCIENCES PRIVATE LIMITED EQ NEW FV Rs. 2/- | Healthcare | 2.28% |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | Healthcare | 2.28% |
| Dr Agarwals Health Care Ltd. | Healthcare | 2.08% |
| GLOBAL HEALTH LIMITED EQ | Healthcare | 1.98% |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | Healthcare | 1.97% |
| Ami Organics Limited | Basic Materials | 1.93% |
| Sector | Holdings | Weight |
|---|---|---|
| Pharmaceuticals & Biotechnology | 17 | 68.82% |
| Healthcare Services | 7 | 22.62% |
| Chemicals & Petrochemicals | 2 | 4.69% |
Active bets vs the average Equity fund. Biggest deviations shown first.
Accent bar = fund's actual sector weight. Vertical black tick = category average for the same sector. Green overlay = overweight, dashed red = underweight. The biggest active bets show first.
How crowded into the same stocks is this fund vs the largest fund in its category?
Category leader = highest-AUM scheme in the same SEBI category. A high overlap-of-weight number means the fund is concentrated into the same names as the leader (crowded); a low one means it's genuinely differentiated.
| P75 |
|---|
| Max |
|---|
| Positive % |
|---|
| 1Y | -6.75% | 1.06% | 13.14% | 32.11% | 61.94% | 80.2% |
Each cell is one year. Q1 = top quartile within the AMFI category for that period. Cell label is the last two digits of the year.
Top-10 weight 55.7% means concentration is in line with most actively-managed Indian equity funds. Effective-N is the inverse Herfindahl index — a measure of "how many positions effectively drive the fund" after weighting. Category: Equity.
Compounding maths on a notional ₹10 lakh lumpsum at 12% gross annual return. Green bar is what you'd have without the fee; red overlay is the fee drag. Fee is constant in this scenario — actual outcomes depend on real returns and any future TER changes.
Each row is a back-tested SIP — monthly contribution over the regime's duration, no fees adjustment beyond NAV-baked TER. XIRR is the annualised IRR of those cashflows; Abs return is the absolute cash-on-cash; Max DD is the deepest drawdown experienced mid-investment. Past performance is not indicative of future results.
Alpha is the annualised excess return vs benchmark over the manager's tenure on this scheme. Beat-benchmark = total return beat the index over the same window.
| 5Y |
|---|
| Star |
|---|
| UTI Healthcare Fund - Regular Plan - Growth Option | UTI Mutual Fund | ₹1,144 Cr | 2.30% | +25.58% | +13.65% | 3★ |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | SBI Mutual Fund | ₹4,323 Cr | 1.90% | +24.26% | +15.05% | 3★ |
| Mirae Asset Healthcare Fund -Regular Growth | Mirae Asset Mutual Fund | ₹2,939 Cr | 2.04% | +24.16% | +13.98% | 3★ |
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Aditya Birla Sun Life Mutual Fund | ₹901 Cr | 2.27% | +22.88% | +12.34% | 3★ |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Tata Mutual Fund | ₹1,325 Cr | 2.21% | +21.66% | +13.09% | 3★ |
| DSP Healthcare Fund - Regular Plan - Growth | DSP Mutual Fund | ₹3,142 Cr | 2.12% | +21.24% | +13.81% | 3★ |
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | ITI Mutual Fund | ₹230 Cr | 4.84% | +19.12% | — | 3★ |
| quant Healthcare Fund - Growth Option - Regular Plan | Quant Mutual Fund | ₹351 Cr | 2.47% | — | — | 2★ |
| Kotak Healthcare Fund - Regular Plan - Growth Option | Kotak Mahindra Mutual Fund | ₹496 Cr | 2.54% | — | — | 2★ |
| WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth | WhiteOak Capital Mutual Fund | ₹603 Cr | 2.57% | — | — | 2★ |